Skip to main content
Biochemistry and Biophysics Reports logoLink to Biochemistry and Biophysics Reports
. 2015 Dec 17;5:509. doi: 10.1016/j.bbrep.2015.12.005

Corrigendum to: ‘‘Salbutamol inhibits ubiquitin-mediated survival motor neuron protein degradation in spinal muscular atrophy cells’’ [Biochem. Biophys. Rep. 4 (2015) 351–356]

Nur Imma Fatimah Harahap a, Dian Kesumapramudya Nurputra a, Mawaddah Ar Rochmah a, Ai Shima a, Naoya Morisada a,b, Toru Takarada c, Atsuko Takeuchi c, Yumi Tohyama d, Shinichiro Yanagisawa e, Hisahide Nishio a,b,
PMCID: PMC5598499

The authors regret that a phrase, “of exon 7”, was mistakenly omitted from the second paragraph of the Introduction section.

The second paragraph should be as follows: “The survival motor neuron genes SMN1 (telomeric SMN) and SMN2 (centromeric SMN) have been identified as candidate SMA-causing genes at chromosome 5q11.2–13.3 [2]. SMN1 and SMN2 are largely identical, but nucleotide +6 of exon 7 in the coding region is a C in SMN1 and a T in SMN2, though these are synonymous and do not result in an amino acid change. However, SMN1, but not SMN2, is now recognized as an SMA-causing gene, because SMN1 is completely deleted in more than 90% of SMA patients [3] and deleteriously mutated in the remaining patients [4].”

The correction above does not affect the results and conclusions of the paper.

The authors would like to apologise for any inconvenience caused.


Articles from Biochemistry and Biophysics Reports are provided here courtesy of Elsevier

RESOURCES